CIK 0001787306
- Large accelerated filer
Arcutis Biotherapeutics, Inc.
Sign in to watch- Ticker
- ARQT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812974255
- Phone
- +1 805-418-5006
- Business address
- 3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
- Former names
- Arcutis, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,253,826
- in 9 filings, $2.1M under 10b5-1 plans
Net −$3,253,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-05 | Watanabe Todd Franklin President and CEO | Sale | −1,000 | $21.76 | $22K | 658,667 |
| 2022-05-02 | Welgus Howard G. Director | Exercise or conversion | +1,496 | $0.58 | $868 | 183,392 |
| 2022-05-02 | Welgus Howard G. Director | Exercise or conversion | +1,004 | $1.68 | $2K | 184,396 |
| 2022-05-02 | Welgus Howard G. Director | Sale | −2,500 | $20.44 | $51K | 181,896 |
| 2022-05-02 | Welgus Howard G. Director | Exercise or conversion · Stock Option (Right to Buy) | −1,496 | 6,110 | ||
| 2022-05-02 | Welgus Howard G. Director | Exercise or conversion · Stock Option (Right to Buy) | −1,004 | 43,978 | ||
| 2022-04-21 | OSBORNE DAVID W Chief Technical Officer | Sale | −2,197 | $20.42 | $45K | 257,229 |
| 2022-04-08 | ORBIMED ADVISORS LLC 10% owner | Sale | −97,200 | $20.71 | $2.0M | 3,840,564 |
| 2022-04-08 | ORBIMED ADVISORS LLC 10% owner | Sale | −102,800 | $20.71 | $2.1M | 451,086 |
| 2022-04-07 | ORBIMED ADVISORS LLC 10% owner | Sale | −167,800 | $20.66 | $3.5M | 3,937,764 |
| 2022-04-07 | ORBIMED ADVISORS LLC 10% owner | Sale | −177,196 | $20.66 | $3.7M | 553,886 |
| 2022-04-06 | ORBIMED ADVISORS LLC 10% owner | Sale | −162,000 | $20.69 | $3.4M | 4,105,564 |
| 2022-04-06 | ORBIMED ADVISORS LLC 10% owner | Sale | −171,204 | $20.69 | $3.5M | 731,082 |
| 2022-04-05 | Watanabe Todd Franklin President and CEO | Sale | −1,000 | $21.43 | $21K | 659,667 |
| 2022-04-01 | Welgus Howard G. Director | Exercise or conversion | +7,500 | $0.58 | $4K | 189,396 |
| 2022-04-01 | Welgus Howard G. Director | Sale | −7,500 | $20.02 | $150K | 181,896 |
| 2022-04-01 | Welgus Howard G. Director | Exercise or conversion · Stock Option (Right to Buy) | −7,500 | 7,606 | ||
| 2022-03-23 | Turney Patricia A. SVP, Operations | Exercise or conversion | +15,331 | $6.52 | $100K | 46,444 |
| 2022-03-23 | Turney Patricia A. SVP, Operations | Exercise or conversion · Stock Option (Right to Buy) | −15,331 | 144,612 | ||
| 2022-03-23 | Turney Patricia A. SVP, Operations | Exercise or conversion | +25,328 | $6.52 | $165K | 56,441 |
Page 30 of 35 · 689 trades